ClinicalTrials.gov · NCT04608448 · Completed
Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock
Registry record
NCT04608448 on ClinicalTrials.gov. The registry's last update to this record was 19 July 2023.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor The University of Texas Health Science Center at San Antonio Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Rapamycin Topical Ointment; Placebo Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in Epigenetic Markers Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Completed Checked Source clinicaltrials.gov Overall status as registered; registry last update 2023-07-19. Checked
Check history: NCT04608448 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: The University of Texas Health Science Center at San Antonio
- Phase: Early Phase 1
- Status: Completed
- Intervention: Rapamycin Topical Ointment; Placebo
- Primary outcome: Change in Epigenetic Markers
- Countries: United States
- Start: 28 April 2021
- Completion (actual): 15 April 2022
Results
Results are posted on the registry. Read them on ClinicalTrials.gov. The Atlas does not summarize findings.
Related modality